(Q43640829)

25 November 2017

title

Primary immune system effects of the orally administered cyclopentane neuraminidase inhibitor RWJ-270201 in influenza virus-infected mice (English)

1 reference

25 November 2017

R W Sidwell

1

1 reference

25 November 2017

D F Smee

series ordinal

2

1 reference

25 November 2017

K W Bailey

series ordinal

3

1 reference

25 November 2017

R A Burger

series ordinal

4

1 reference

25 November 2017

publication date

1 June 2001

1 reference

International Immunopharmacology

25 November 2017

published in

1 reference

25 November 2017

volume

1

1 reference

25 November 2017

issue

6

1 reference

25 November 2017

page(s)

1211-1218

1 reference

Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900058-3

7 January 2021

Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900058-3

7 January 2021

The molecular biology of influenza virus pathogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900058-3

7 January 2021

BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900058-3

7 January 2021

Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900058-3

7 January 2021

In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900058-3

7 January 2021

The immunology of influenza

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900058-3

7 January 2021

Immunological effects of the orally administered neuraminidase inhibitor oseltamivir in influenza virus-infected and uninfected mice

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900058-3

7 January 2021

Utilization of pulse oximetry for the study of the inhibitory effects of antiviral agents on influenza virus in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900058-3

7 January 2021

Effect of methionine enkephalin on natural killer cell and cytotoxic T lymphocyte activity in mice infected with influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900058-3

7 January 2021

Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900058-3

7 January 2021

Antiviral activity of an immunomodulatory lipophilic desmuramyl dipeptide analog

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900058-3

7 January 2021

Leukocyte Interleukin, Inj. (LI) augmentation of natural killer cells and cytolytic T-lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900058-3

7 January 2021

Severe herpesvirus infections in an adolescent without natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900058-3

7 January 2021

Production of multiple cytokines by clones of human large granular lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900058-3

7 January 2021

The role of natural killer cells in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900058-3

7 January 2021

10.1016/S1567-5769(01)00058-3

Identifiers

DOI

1 reference

25 November 2017

1 reference